| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers (NCT05844787) | Mthera Pharma Co., Ltd. | 2022-07-11 |
| Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE) (NCT05377281) | Craig van Horne, MD, PhD | 2022-07-07 |
| Serotonin Release in Premotor and Motor PD (NCT05516732) | University of Exeter | 2022-07-01 |
| Biomarkers of Neurodegeneration and Neuroplasticity in Parkinson's Disease Patients Treated by Bilateral M1-iTBS (NCT06840145) | Instituto de investigación e innovación biomédica de Cádiz | 2022-06-01 |
| Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease (NCT03309514) | NeuroGeneration | 2022-06-01 |
| A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease (NCT05435729) | Sumitomo Pharma Co., Ltd. | 2022-05-31 |
| Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects (NCT04735172) | University Hospital, Clermont-Ferrand | 2022-04-07 |
| Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease (NCT05298150) | VA Office of Research and Development | 2022-04-01 |
| Development and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease (NCT04933513) | Central Hospital, Nancy, France | 2022-03-30 |
| Interleaving Stimulation Improves Dyskinesia in Parkinson's Disease (NCT06239454) | Huashan Hospital | 2022-03-01 |
| Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump) (NCT05072015) | University Hospital, Strasbourg, France | 2022-02-01 |
| Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease (NCT05094050) | AbbVie | 2022-01-18 |
| MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD (NCT05471713) | Zhujiang Hospital | 2022-01-01 |
| Attentional Performance in Parkinson Disease (NCT04428931) | National Institute of Neurological Disorders and Stroke (NINDS) | 2021-12-06 |
| Ketamine for the Treatment of Depression in Parkinson's Disease (NCT04944017) | Yale University | 2021-11-23 |
| An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD) (NCT05638815) | SciNeuro | 2021-11-23 |
| Effects of Probiotics on Peripheral Immunity in Parkinson's Disease (NCT05173701) | Franca Marino | 2021-11-22 |
| Longitudinal Investigation of I2BS in PD (NCT05516719) | University of Exeter | 2021-11-01 |
| The Swedish BioFINDER Sleep Study (NCT07533799) | Skane University Hospital | 2021-10-01 |
| Relative Bioavailability Study of HRG2010 in Healthy Subjects (NCT06976346) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-10 |
| PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease (NCT04396873) | National Institute of Mental Health (NIMH) | 2021-08-17 |
| Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease (NCT05992701) | Beijing Pins Medical Co., Ltd | 2021-07-28 |
| The Practical Effect of Neupro (NCT04957420) | Peking University Third Hospital | 2021-07-01 |
| Predictive Value of Multimodal MRI in Parkinson's Disease (NCT05003206) | Chinese PLA General Hospital | 2021-06-19 |
| Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients (NCT04778176) | SynAgile Corporation | 2021-06-16 |
| Parkinson's Disease G2019S LRRK2 Genetic Testing Program (NCT04919356) | Escape Bio, Inc. | 2021-06-08 |
| Vestibulopathy as a Cause of Imbalance in Parkinson (NCT04768647) | VA Office of Research and Development | 2021-05-28 |
| Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease (NCT05034263) | Stony Brook University | 2021-05-27 |
| Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease (NCT04799470) | University of Nebraska | 2021-05-10 |
| Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipation (NCT04837313) | Guangzhou First People's Hospital | 2021-05-01 |
| A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease (NCT04867642) | UCB Biopharma SRL | 2021-04-29 |
| Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel (NCT04500106) | AbbVie | 2021-04-22 |
| Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease (NCT05901818) | Xuanwu Hospital, Beijing | 2021-04-01 |
| Objective Assessment of Behavioural Disorders in PD (NCT04611581) | Insel Gruppe AG, University Hospital Bern | 2021-04-01 |
| Short Pulse Width Versus Low Frequency DBS in Parkinson's Disease (NCT05034510) | University Hospital of Ferrara | 2021-03-20 |
| to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers (NCT04593511) | Luye Pharma Group Ltd. | 2021-02-02 |
| Partnered Dance Aerobic Exercise as a Neuroprotective, Motor and Cognitive Intervention in Parkinson's Disease (NCT04122690) | VA Office of Research and Development | 2021-01-25 |
| Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) (NCT04584346) | National Institute of Neurological Disorders and Stroke (NINDS) | 2021-01-21 |
| Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain (NCT06445465) | Invicro | 2020-12-24 |
| Parkinson's Foundation PD GENEration Genetic Registry (NCT04994015) | Parkinson's Foundation | 2020-12-20 |
| Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's Disease (NCT04652843) | Nantes University Hospital | 2020-12-17 |
| A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD) (NCT04651153) | UCB Biopharma SRL | 2020-12-14 |
| International Validation of Two Non-motor Scales in PD (NFS and SPARK) (NCT04366804) | Insel Gruppe AG, University Hospital Bern | 2020-12-03 |
| Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease (NCT04506073) | The University of Texas Health Science Center, Houston | 2020-11-09 |
| Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD) (NCT04565080) | National Institute of Neurological Disorders and Stroke (NINDS) | 2020-10-29 |
| Simpler and Safer Deep Brain Stimulation for Parkinson's Disease (NCT03837314) | North Bristol NHS Trust | 2020-10-28 |
| Cognitive-motor Training for PD (NCT01917903) | Stony Brook University | 2020-10-26 |
| Research on the Effect and Mechanism of Aerobic Exercise on PD (NCT04651140) | The First Hospital of Jilin University | 2020-10-13 |
| Stereotactic Transplantation of hAESCs for Parkinson's Disease (NCT04414813) | Shanghai East Hospital | 2020-10-08 |
| Mapping the Target for the MRgFUS Treatment of Tremor (NCT04661241) | NYU Langone Health | 2020-09-10 |
| Sensory-specific Peripheral Stimulation for Tremor Management (NCT04501133) | Shirley Ryan AbilityLab | 2020-09-01 |
| Interactive Stepping Exercise on Balance and Cognitive Function (NCT04494906) | National Yang Ming Chiao Tung University | 2020-08-19 |
| Remote Ischemic Conditioning for Parkinson's Disease (NCT04327687) | General Hospital of Shenyang Military Region | 2020-08-18 |
| Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease (NCT04449484) | AstraZeneca | 2020-08-04 |
| Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets (NCT04275492) | First Affiliated Hospital of Zhejiang University | 2020-07-24 |
| Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care (NCT04179695) | University Hospital, Lille | 2020-07-21 |
| Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease (NCT04926909) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-07-01 |
| Poised for Parkinson's - an Intervention to Increase Embodied Agency in People With Parkinson's Disease and Their Carers (NCT04726709) | University of Idaho | 2020-06-05 |
| Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease (NCT06365190) | Anhui Medical University | 2020-04-06 |
| rTMS to Improve Cognition in Parkinson's (NCT03836950) | VA Office of Research and Development | 2020-04-01 |
| GDNF Gene Therapy for Parkinson's Disease (NCT04167540) | Brain Neurotherapy Bio, Inc. | 2020-04-01 |
| A Through QT/QTc Study of KW-6356 (NCT04342273) | Kyowa Kirin Co., Ltd. | 2020-03-31 |
| A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease (NCT04127695) | AbbVie | 2020-03-03 |
| Induction and Recognition of Emotions (NCT04353947) | University of Valencia | 2020-03-02 |
| Genotypic Influences on Network Progression in Parkinson's Disease (NCT04228172) | Northwell Health | 2020-02-24 |
| Cognitive Rehab for Parkinson's (NCT03836963) | VA Office of Research and Development | 2020-01-27 |
| Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (NCT04232969) | University College, London | 2020-01-20 |
| Low Dose Niacin (Vitamin B3) for Parkinson's Disease (NCT03808961) | VA Office of Research and Development | 2020-01-01 |
| Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study (NCT03998462) | VA Office of Research and Development | 2020-01-01 |
| 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease (NCT03815916) | Clene Nanomedicine | 2019-12-19 |
| An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD (NCT03994328) | Zambon SpA | 2019-12-03 |
| Using DBS to Probe Basal Ganglia Dysfunction (NCT04080674) | University of Oxford | 2019-12-01 |
| A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease (NCT03436953) | Jazz Pharmaceuticals | 2019-12-01 |
| Gait Characteristics and Cognitive Evolution in Parkinson Disease (NCT04297800) | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 2019-11-09 |
| Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine (NCT04164758) | ACADIA Pharmaceuticals Inc. | 2019-10-23 |
| Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease (NCT04157933) | Alexza Pharmaceuticals, Inc. | 2019-10-16 |
| Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects (NCT04165837) | 1ST Biotherapeutics, Inc. | 2019-10-14 |
| Circadian & Homeostatic Synchronization Effect on Waking Mobility in Parkinson's Disease (NCT04467632) | University Hospital Center of Martinique | 2019-10-01 |
| Highly Challenging Balance Program to Reduce Fall Rate in PD (NCT03972969) | VA Office of Research and Development | 2019-10-01 |
| Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (NCT04006210) | NeuroDerm Ltd. | 2019-09-30 |
| Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease (NCT04308135) | Ain Shams University | 2019-09-01 |
| Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease (NCT04046276) | Assistance Publique - Hôpitaux de Paris | 2019-09-01 |
| Study of UB-312 in Healthy Participants and Parkinson's Disease Patients (NCT04075318) | United Neuroscience Ltd. | 2019-08-29 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease (NCT03976349) | Ionis Pharmaceuticals, Inc. | 2019-08-12 |
| Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects (NCT04043338) | Xoc Pharmaceuticals | 2019-08-11 |
| Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease (NCT04578678) | Insel Gruppe AG, University Hospital Bern | 2019-08-09 |
| Telehealth Psychotherapy for Depression in Parkinson's Disease (NCT03993041) | Boston University Charles River Campus | 2019-08-01 |
| Concurrent Transcranial Direct Current Stimulation and Gait Training in Parkinson's Disease (NCT04041661) | National Yang Ming Chiao Tung University | 2019-08-01 |
| Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease (NCT06021756) | University of Arizona | 2019-07-28 |
| Study to Evaluate DNL151 in Subjects With Parkinson's Disease (NCT04056689) | Biogen | 2019-07-23 |
| Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai (NCT04023201) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2019-07-03 |
| The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. (NCT03945968) | Russian Federation of Anesthesiologists and Reanimatologists | 2019-07-01 |
| Aerobic Exercise in Parkinson's Disease (NCT03808675) | VA Office of Research and Development | 2019-07-01 |
| Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool (NCT03794661) | Abbott Medical Devices | 2019-06-26 |
| Predicting Cognition After DBS for Parkinson's Disease (NCT03982953) | Charite University, Berlin, Germany | 2019-06-12 |
| Cognitive Control in Parkinson's Disease (NCT03981913) | Rennes University Hospital | 2019-06-06 |
| Rostock International Parkinson's Disease Study (ROPAD) (NCT03866603) | CENTOGENE GmbH Rostock | 2019-05-30 |
| A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin (NCT03970798) | Kyowa Kirin Co., Ltd. | 2019-05-22 |
| Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease: (NCT03552068) | Hospices Civils de Lyon | 2019-05-15 |
| A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD) (NCT04875962) | UCB Biopharma S.P.R.L. | 2019-05-06 |